Scientific article
Meta-analysis
OA Policy
English

Drug treatments for covid-19: living systematic review and network meta-analysis

Published inBMJ (Clinical Research Edition), vol. 370, m2980
Publication date2020
Abstract

To compare the effects of treatments for coronavirus disease 2019 (covid-19).

Keywords
  • Adenosine Monophosphate/analogs & derivatives/therapeutic use
  • Alanine/analogs & derivatives/therapeutic use
  • Antiviral Agents/therapeutic use
  • Betacoronavirus/isolation & purification/pathogenicity
  • Centers for Disease Control and Prevention, U.S./statistics & numerical data
  • China/epidemiology
  • Coronavirus Infections/diagnosis/drug therapy/mortality/therapy/virology
  • Databases, Factual/statistics & numerical data
  • Drug Combinations
  • Evidence-Based Medicine/methods/statistics & numerical data
  • Glucocorticoids/therapeutic use
  • Humans
  • Hydroxychloroquine/therapeutic use
  • Lopinavir/therapeutic use
  • Network Meta-Analysis
  • Pandemics
  • Pneumonia, Viral/diagnosis/mortality/therapy/virology
  • Randomized Controlled Trials as Topic
  • Respiration, Artificial/statistics & numerical data
  • Ritonavir/therapeutic use
  • Severity of Illness Index
  • Standard of Care
  • Treatment Outcome
  • United States/epidemiology
Citation (ISO format)
SIEMIENIUK, Reed Ac et al. Drug treatments for covid-19: living systematic review and network meta-analysis. In: BMJ (Clinical Research Edition), 2020, vol. 370, p. m2980. doi: 10.1136/bmj.m2980
Main files (1)
Article (Published version)
Identifiers
Additional URL for this publicationhttps://www.bmj.com/content/370/bmj.m2980
Journal ISSN0959-8138
351views
388downloads

Technical informations

Creation23/08/2020 18:13:00
First validation23/08/2020 18:13:00
Update15/03/2023 22:35:28
Status update15/03/2023 22:35:22
Last indexation14/03/2025 17:07:15
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack